"At the Sandra Atlas Bass Center for Liver Diseases, board-certified physicians provide specialized treatment and management for all aspects of liver diseases, including comprehensive evaluations and postsurgical care for liver transplants. Our multidisciplinary team of hepatologists, liver transplant surgeons, interventional radiologists, medical oncologists and other specialists combine their expertise with cutting-edge therapies to bring you the integrated, seamless care you deserve."

During the past decade, Northwell Health Center for Liver Diseases and Transplantation conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwell Health Center for Liver Diseases and Transplantation" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Target PharmaSolutions, Inc." with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Assembly Biosciences" with 1 trials sponsored and "CymaBay Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwell Health Center for Liver Diseases and Transplantation" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Northwell Health Center for Liver Diseases and Transplantation" are "Nonalcoholic Steatohepatitis" (3 trials), "Primary Sclerosing Cholangitis" (2 trials), "Chronic Hepatitis B" (1 trials), "Compensated Cirrhosis" (1 trials) and "Hepatitis" (1 trials). Many other conditions were trialed in "Northwell Health Center for Liver Diseases and Transplantation" in a lesser frequency.

Most popular intervention types in "Northwell Health Center for Liver Diseases and Transplantation" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials) and "ABI-H2158" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwell Health Center for Liver Diseases and Transplantation" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Northwell Health Center for Liver Diseases and Transplantation". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northwell Health Center for Liver Diseases and Transplantation, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Northwell Health Center for Liver Diseases and Transplantation, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".